Geen todos los medicamentos afectan por igual a todas las personas. For this reason, the medicine is intended to optimize the administration of medicines according to the specific conditions of each patient. It is what has been named as pharmacogenomics, which combines pharmacology and genomics, the increased science of studying the genes and their functions, with the proposal to develop new drugs. If you want to study the form in which the individuals respond individually to the pharmacies.
This study can be applied to more effective and safe doses, adapted to the variations of a person’s genes. Individualizing the treatments, we apply to the concept of precision and personalized medicine, that it is necessary to monitor medical attention. In the practice above that, before administering a pharmacy tuviese in account of the patient’s genetic profile, in order to try and keep in mind the expected effects of antimony.
To make a prognosis of the possible response of a patient to a drug, the personalized medicine is analyzed in conjunction with his genomic, clinical, and patient data. With all this information, it is possible to avoid possible secondary effects and to increase the efficiency of the treatments. This type of personalized medicine is applied, for example, to treat cancer, using the specific tumor information of the person affected with the object of consulting the best in the diagnostic, the planning of the treatment or see if it is the most effective. In this sense, suele is employed in guided therapies to treat cancerous cells determined.
The technology that makes it possible
The incorporation of Big Data into the healthcare sector allows for the maneuvering and posterior analysis of any information, even vital, for the development of a personalized medicine. Thanks to the application of this technology has given a strong impetus to the genomics. Asia, Big data allows you to do population studies for place each person in groups of different types of risk, as well as, medium, high, ensemble, respect to concrete towers. In this sense, según Urko M. Marigorta, researcher of the CIC bioGUNE (@CICbioGUNE), it is possible to study the genome of a patient “with his genetic risk and select the 1.5% or 10% of individuals with a risk of pathological pathogens, for 50 euros”.
In addition to quantum computing, a computing model distinct from classical informatics capable of generating much more information and increasing the speed of the computers, it facilitates the development of personalized medicine and new pharmaceuticals. Spain has a Spanish Strategy for Personalized Medicine, written inside the Choke Plan for Science and Innovation, approved by the Government in July 2020, and has a budget of 25.8 million euros. This strategy consists of several plans: Genome Medicine, Digital Health and Data Science Plan, one of Advanced and Personalized Therapies, and a Predictive Medicine Plan, among others.